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ABSTRACT: We report the preparation of S-aroylthiooxime (SATO)
functionalized amphiphilic block copolymer micelles that release
hydrogen sulﬁde (H2S), a gaseous signaling molecule of relevance to
various physiological and pathological conditions. The micelles release
H2S in response to cysteine with a half-life of 3.3 h, which is
substantially slower than a related small molecule SATO. Exogenous
administration of H2S impacts growth and proliferation of cancer cells;
however, the limited control over H2S generation from inorganic
sulﬁde sources results in conﬂicting reports. Therefore, we compare the cellular cytotoxicity of SATO-functionalized micelles,
which release H2S in a sustained manner, to Na2S, which releases H2S in a single dose. Our results show that H2S-releasing
micelles signiﬁcantly reduce the survival of HCT116 colon cancer cells relative to Na2S, GYY4137, and a small molecule SATO,
indicating that release kinetics may play an important role in determining toxicity of H2S toward cancer cells. Furthermore, H2S-
releasing micelles are well tolerated by immortalized ﬁbroblasts (NIH/3T3 cells), suggesting a selective toxicity of H2S toward
cancer cells.
KEYWORDS: gasotransmitter, H2S donors, controlled release, polymer amphiphiles, RAFT
■ INTRODUCTION
Hydrogen sulﬁde (H2S) belongs to a classiﬁcation of
biologically relevant signaling gases known as gasotransmitters.1
Gasotransmitters, which also include nitric oxide (NO) and
carbon monoxide (CO), have attracted much interest in recent
years due to their extensive roles in cellular signaling.2 For
example, H2S regulates vasodilation, promotes angiogenesis,
and generally exhibits beneﬁcial eﬀects as an anti-inﬂammatory
agent.3−8 To support these biological studies, new chemical
tools have been developed over the past ∼5 years. These
include H2S sensors, which report on H2S concentrations in
vivo and in vitro,9−12 compounds triggered by endogenous H2S
to release drugs,13 and compounds that release H2S (H2S
donors),14−22 usually through decomposition reactions initiated
by a speciﬁc trigger.
The gaseous nature of H2S and its fast reactivity in biological
systems make controlled delivery a necessity and a diﬃcult
challenge. To date, most studies of H2S biology have been
conducted with sulﬁde salts (Na2S and NaSH). These inorganic
sulﬁde sources generate H2S instantaneously upon dissolution,
resulting in a rapid surge in H2S concentration followed by a
rapid decline. While experimentally convenient, sulﬁde salts can
convolute the results of biological studies due to their rapid
release, as the activity of H2S profoundly depends on its local
concentration. For example, evidence suggests that H2S could
be an eﬀective therapeutic candidate due its ability to selectively
reduce survival in cancer cells.23,24 This is likely the result of the
high set point of oxidative stress that cancer cells maintain,
making them more susceptible than healthy cells to the
cytotoxic pro-oxidant eﬀects exhibited by H2S in highly
oxidative environments.25 Additionally, H2S passes through
biological membranes without active transport mechanisms,3
which may enable deep penetration into the tumor interstitium,
a major problem with traditional small molecule chemo-
therapeutics.26 Conversely, endogenous levels of H2S provide a
route for some cancer cells to evade standard treatment
strategies by promoting angiogenesis, augmenting mitochon-
drial bioenergetics, activating antiapoptotic pathways, and
controlling cell cycle progression.27,28 This apparent discrep-
ancy over the response of cancer cells to H2S may arise from
diﬀerent release rates among diﬀerent H2S donors.
23 Therefore,
this and other challenges in H2S biology may be resolved by
developing advanced delivery vehicles that produce well-
deﬁned quantities of H2S over controllable time scales.
In the past few years, reports have appeared of a multitude of
H2S-releasing small molecules that more aptly mimic the
sustained endogenous production of the gas in vivo.14−22
However, many small molecule H2S donors suﬀer from
limitations such as ill-deﬁned release mechanisms, poor water
solubility, and inherent (or latent) toxicity. Such small molecule
H2S donors also typically have no capacity for targeting any
speciﬁc organ and therefore only provide systemic delivery of
H2S. More recently, a handful of polymers that release H2S
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have addressed some shortcomings of small molecule H2S
donors.29−33 However, these also have limitations: linear
polymers are typically too small to avoid rapid renal clearance
in the bloodstream and have limited capacity for targeting a
speciﬁc site in the body. Polymer micelles made from
amphiphilic block copolymers address these challenges because
they are typically in the ideal size range (20−100 nm) for long
bloodstream circulation and can target speciﬁc sites in the body
(e.g., a solid tumor) through either passive or active
mechanisms.34,35 Polymer micelles that combine controlled
H2S release with the capacity for in vivo targeting and long
bloodstream circulation are therefore needed to advance the
ﬁeld of H2S biology and to develop novel therapeutics. We
present in this report initial eﬀorts to develop polymer micelles
as advanced H2S delivery vehicles, which we use here for
studying toxicity toward a cancer cell line.
■ MATERIALS AND METHODS
Materials. All reagents were obtained from commercial
vendors and used as received unless otherwise stated. 2,2′-
Azobis(2-methylpropionitrile) (AIBN) was recrystallized from
methanol prior to use. S-Aroylthiohydroxylamine (SATHA)
and SATO1 ((C6H5)COSNCH(C6H4)COOH) were
prepared according to a previously reported procedure.17 The
monomer 2-(4-formylbenzoyloxy)ethyl methacrylate
(FBEMA) was also synthesized as previously reported.29 Dry
solvents were puriﬁed by passage through a solvent puriﬁcation
system (MBraun).
Methods. NMR spectra were measured on an Agilent 400
MHz spectrometer. 1H and 13C NMR chemical shifts are
reported in ppm relative to internal solvent resonances. Yields
refer to chromatographically and spectroscopically pure
compounds unless otherwise stated. Size exclusion chromatog-
raphy (SEC) was carried out in THF at 1 mL/min at 30 °C on
two Agilent PLgel 10 μm MIXED-B columns connected in
series with a Wyatt Dawn Heleos 2 light scattering detector and
a Wyatt Optilab Rex refractive index detector. No calibration
standards were used, and dn/dc values were obtained by
assuming 100% mass elution from the columns. TEM samples
were drop cast from 1 mg/mL solutions of micelles in H2O
onto carbon-coated copper 300 mesh TEM grids (Electron
Microscopy Sciences). Samples were then stained with a 2%
solution of uranyl acetate in water. Images were taken on a
Philips EM420 TEM with a slow scan CCD camera. UV−vis
absorbance spectra were recorded on a Cary 5000 UV−vis
spectrophotometer (Agilent) from 800 to 550 nm or on a
Spectramax M2 plate reader (Molecular Devices). Dynamic
light scattering (DLS) was conducted using a Malvern Zetasizer
Nano operating at 25 °C. A solution of micelles was prepared at
1 mg/mL and ﬁltered with a 0.2 μm ﬁlter prior to scanning.
The calculations of the particle size distributions and
distribution averages were conducted using CONTIN particle
size distribution analysis routines with intensity averages.
Measurements were made in triplicate, and errors reﬂect
standard deviations.
Synthesis of 4-Cyano-4-(dodecylsulfanylthio-
carbonyl)sulfanyl Pentanoic Acid (CTA). Dodecanethiol
(10 mL, 41.7 mmol) was dissolved in hexanes (150 mL) in a
round-bottom ﬂask. To the ﬂask was added a solution of
potassium tert-butoxide (4.68 g, 41.7 mmol) in THF (50 mL).
The reaction mixture was stirred at rt for 20 min. CS2 was
added (2.7 mL, 44.7 mmol), and the reaction mixture was
stirred for an additional 1 h. I2 was then added in portions until
the reaction mixture maintained a persistent dark brown color.
The reaction mixture was stirred overnight at rt. The reaction
mixture was transferred to a separatory funnel and washed
consecutively with 10% Na2S2O3, H2O, and brine. The organic
layer was then dried over Na2SO4 and rotovapped.
The resulting viscous yellow oil (22.8 g, 41.1 mmol) was
redissolved in EtOAc (100 mL) in a round-bottom ﬂask. To the
ﬂask was added 4,4′-azobis(4-cyanovaleric acid) (11.6 g, 41.4
mmol). The reaction mixture was heated at reﬂux overnight.
Silica gel was poured into the reaction ﬂask, and the silica slurry
was rotovapped to dryness. The silica was then dry-loaded onto
a silica gel column, eluting with 9:1 hexanes/EtOAc. The
product-containing fractions (Rf ≈ 0.3 in the mobile phase)
were combined and rotovapped to give the product as a yellow
solid (9.50 g, 57% yield). 1H NMR (CDCl3): δ 3.33 (t, J = 4
Hz, 2H), 2.68 (t, J = 4 Hz, 2H), 2.54 (m, 1H), 2.39 (m, 1H),
1.88 (s, 3H), 1.69 (q, J = 8 Hz, 2H), 1.45−1.19 (m, 18H), 0.88
(t, J = 4 Hz, 3H). 13C NMR (CDCl3): δ 216.88, 177.63, 118.99,
46.30, 37.21, 33.58, 32.03, 29.74, 29.67, 29.66, 29.54, 29.46,
29.19, 29.05, 27.78, 24.96, 22.81, 14.25. HR-MS: [M + H]+
calculated 404.1746; found 404.1749.
Synthesis of macroCTA. A round-bottom ﬂask was
charged with CTA (0.81 g, 2.01 mmol), polyethylene glycol
monomethyl ether (Mn = 5000 g/mol, 2.0 g, 0.400 mmol), 4-
dimethylamino pyridine (0.12 g, 0.982 mmol), and anhydrous
CH2Cl2 (40 mL). N,N′-Dicyclohexylcarbodiimide (DCC)
(0.41 g, 1.99 mmol) was dissolved in 5 mL of anhydrous
CH2Cl2 in a vial. The DCC solution was added dropwise to the
ﬂask containing the other reagents, and the reaction mixture
was stirred at rt overnight. The precipitated solids were
removed by ﬁltration. The desired product was isolated via
precipitation from diethyl ether and was puriﬁed by repeated
precipitations (2−4) from CH2Cl2 into diethyl ether to aﬀord
the product as a yellow solid (1.50 g, 69% yield). 1H NMR
(CDCl3): δ 4.24 (t, J = 4 Hz, 2H), 3.80 (t, J = 4 Hz, 2H), 3.71−
3.51 (m, 494H), 3.45 (t, J = 4 Hz, 2H), 3.36 (s, 3H), 3.31 (t, J
= 8 Hz, 2H), 2.64 (t, J = 8 Hz, 2H), 2.51 (m, 1H), 2.37 (m,
1H), 1.86 (s, 3H), 1.68 (t, J = 8 Hz, 2H), 1.42−1.18 (m, 18H),
0.87 (t, J = 4 Hz, 3H).
Synthesis of PEG-b-poly(FBEMA). A typical polymer-
ization procedure is as follows: To an oven-dried Schlenk tube
equipped with a magnetic stir bar was added macroCTA (127
mg, 25.0 μmol), FBEMA (1.00 g, 3.81 mmol), and 5 mL of
anhydrous DMF. A solution of 2,2′-azobis(2-methylpropioni-
trile) (AIBN) was prepared by dissolving 4.2 mg (2.54 μmol)
in 1 mL of anhydrous DMF in a vial. One hundred microliters
of this solution was added to the Schlenk tube. The tube was
deoxygenated by subjecting the contents to three freeze−
pump−thaw cycles. The Schlenk tube was then backﬁlled with
N2 and submerged in an oil bath maintained at 75 °C. Samples
were removed periodically by N2-purged syringe to monitor
molecular weight evolution by SEC and conversion by 1H
NMR spectroscopy. The polymerization was quenched by
submerging the tube into liquid N2 and exposing the reaction
solution to air. The resulting PEG-b-poly(FBEMA) was isolated
via precipitation from diethyl ether. If necessary, further
precipitations from CH2Cl2 into diethyl ether were performed
to remove residual monomer.
Removal of Dithioester End Group. A round-bottom
ﬂask was charged with PEG-b-poly(FBEMA) (0.50 g, 14.0
μmol), AIBN (47.0 mg, 284 μmol), and 1,4-dioxane (3 mL).
The ﬂask was outﬁtted with a condenser, and the reaction
mixture was heated in an oil bath maintained at 80 °C for 1.5 h.
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The reaction mixture was allowed to cool to rt, and the polymer
was recovered via precipitation into diethyl ether.
Addition of SATHA to PEG-b-poly(FBEMA). A general
procedure for the SATO formation reaction is as follows.
Following end group removal, PEG-b-poly(FBEMA) (100 mg,
3.21 μmol) was dissolved in CH2Cl2 (3 mL) in a 1 dram vial.
To the vial was added SATHA (147 mg, 962 μmol) in one
portion. Approximately 10 μL of triﬂuoroacetic acid (TFA) was
added as a catalyst. The reaction mixture was left to stand at rt
for 16 h over molecular sieves. 1H NMR spectroscopy was
conducted after this time to determine the conversion of
aldehyde to SATO. The modiﬁed polymer was recovered via
precipitation into diethyl ether.
Determination of Critical Micelle Concentrations
(CMCs). A micelle stock solution was prepared at 0.1 mg/mL
in H2O. This solution was diluted with water to aﬀord
concentrations of 0.05, 0.04, 0.03, 0.02, 0.01, 0.005, 0.001,
0.0001, 0.00001, and 0.000001 mg/mL. Two microliters of a 1
mg/mL Nile red solution in acetone was added to each dilution
to make a ﬁnal volume of 2 mL. The samples were transferred
to a 96-well plate and were placed in a vacuum oven set to 30
°C for at least 2 h to ensure complete evaporation of acetone.
Fluorescence emission spectra were recorded for each sample
(λex = 530 nm), and the emission intensity at 630 nm was
plotted against log(concentration). The CMC value was taken
to be the intersection between the linear ﬁts of the high and low
concentration regimes.
H2S Release Kinetics via the Methylene Blue Method.
Reactions for kinetics studies were run in triplicate, with each
reaction vial containing 20 μL of phosphate buﬀer (1 M in
H2O, pH = 7), micelle solution (volume dependent on polymer
concentration and SATO loading), 100 μL of Zn(OAc)2
solution (40 mM in H2O), 20 μL of cysteine solution (100
mM in H2O), and DI H2O to make 2 mL total volume. Final
concentrations were 250 μM SATO functional groups, 2 mM
Zn(OAc)2, and 1 mM Cys. A blank solution was also run for
each experiment that did not contain micelles. At predeter-
mined time points, 100 μL was removed from each vial. Each
100 μL aliquot was diluted with 100 μL of FeCl3 solution (30
mM in 1.2 M HCl) followed by 100 μL of N,N-dimethyl-p-
phenylenediamine (20 mM in 7.2 M HCl). Aliquots were
stored for a minimum of 24 h after the ﬁnal aliquot had been
taken. The absorbance of each sample was measured at 750 nm
using a plate reader. Kinetic analysis was done by subtracting
the absorbance of the blank solution from the average
absorbance at each time point. First-order half-lives of H2S
release were determined by plotting time vs ln(1/(1 − %
released), with t1/2 = ln(2)/slope. The conversion of the
reaction was obtained by normalizing the absorbance values to
the maximum absorbance that was measured for each
experiment (or the value at which the plot of absorbance vs
time reached a plateau).
Calibration Procedure for the Methylene Blue Assay.
A 15 mM Na2S stock solution was prepared by dissolving 24
mg of Na2S in 20 mL of DI H2O. This solution was then
diluted 10× with H2O to give a 1.5 mM Na2S solution. Na2S
solutions at concentrations ranging from 5 to 100 μM were
prepared in triplicate by mixing the appropriate volume of 1.5
mM Na2S stock solution with 20 μL of 1 M phosphate buﬀer
and then diluting with DI H2O to a total volume of 1 mL.
Samples were prepared by removing 100 μL of each Na2S
solution and diluting with 100 μL of FeCl3 solution (30 mM in
1.2 M HCl) followed by 100 μL of N,N-dimethyl-p-phenyl-
enediamine (20 mM in 7.2 M HCl). Aliquots were stored for a
minimum of 24 h after the ﬁnal aliquot had been taken. The
absorbance of each sample was measured at 750 nm using a
plate reader. A calibration curve was prepared by plotting
absorbance for each data point as a function of [Na2S].
H2S Release Proﬁle via the Methylene Blue Method.
Reactions for measurement of the H2S release proﬁle were
conducted in triplicate, with each reaction vial containing 20 μL
of phosphate buﬀer (1 M in H2O, pH = 7), micelle solution
(volume dependent on polymer concentration and SATO
loading), 20 μL of cysteine solution (100 mM in H2O), and DI
H2O to make 2 mL total volume. Final concentrations were
250 μM SATO functional groups and 1 mM Cys. A blank
solution was also run for each experiment that did not contain
micelles. Additional controls without Cys were also conducted
with and without micelles. At predetermined time points, 100
μL was removed from each vial. Each 100 μL aliquot was
diluted with 100 μL FeCl3 solution (30 mM in 1.2 M HCl)
followed by 100 μL of N,N-dimethyl-p-phenylenediamine (20
mM in 7.2 M HCl). Aliquots were stored for a minimum of 24
h after the ﬁnal aliquot had been taken. The absorbance of each
sample was measured at 750 nm using a plate reader. The
concentration of H2S at each time point was then plotted using
the calibration curve.
Cell Culture and Clonogenic Survival Assay. Colorectal
carcinoma HCT116 cells (ATCC CCL-247) and embryonic
ﬁbroblast NIH/3T3 cells (ATCC CRL-1658) were obtained
from ATCC. HCT116 cells were propagated in HyClone
McCoy’s 5a medium (GE Healthcare), supplemented with 10%
fetal bovine serum (Corning), 50 IU/mL penicillin, and 50 μg/
mL streptomycin (MP Biomedicals). Fibroblasts were main-
tained in ATCC-formulated Dulbecco’s modiﬁed Eagle’s
medium supplemented containing 10% calf serum (ATCC
31334) and penicillin/streptomycin antibiotics as above. For all
experiments, cells were maintained at 37 °C/5% CO2 until
reaching 50−80% conﬂuence.
For clonogenic assays, exponentially growing HCT116 or
NIH/3T3 cells were harvested, and various dilutions of cells
(500 to 2000 cells/well) were seeded into 6-well plates and
allowed to attach overnight in the incubator before adding
diﬀerent formulations. Each cell type was titrated with various
dose-concentration of SATO groups in active micelles ranging
from 50 to 250 μM in the presence of 1 mM Cys for ∼6 h.
Corresponding controls include cells treated with 50−250 μM
Na2S, active micelles at 250 μM SATO in the absence of Cys,
inactive micelles lacking the SATO group (250 μM aldehyde
precursor) in the presence or absence of 1 mM Cys, or 1 mM
Cys alone. Plates were transferred to 37 °C/5% CO2 until cells
in control wells had formed suﬃciently large clones (∼10 days),
after which they were ﬁxed with a mixture of 6%
glutaraldehyde/0.5% crystal violet for 30 min at room
temperature. After removing the ﬁxative, plates with colonies
were allowed to dry at room temperature before manual
counting. The surviving fraction of cells after treatment was
calculated, taking into account the plating eﬃciency of control
cells. All experiments were performed in triplicate, and the
means and standard deviations were plotted using Excel and
tested for statistical signiﬁcance using a paired t test.
■ RESULTS AND DISCUSSION
We recently reported on the S-aroylthiooxime (SATO)
functional group, which represents one type of versatile H2S
donor.17 SATOs were eﬃciently prepared in one step via
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reaction of an S-aroylthiohydroxylamine (SATHA) with an
aromatic aldehyde. H2S release from SATOs was selectively
triggered by a thiol, and release kinetics were ﬁne-tuned by
manipulating the substituents on the aromatic ring of the
parent S-aroylthiohydroxylamine, with half-lives of release
ranging from 8−82 min under the conditions tested. The
SATO-forming reaction was also recently used for postpolyme-
rization modiﬁcation to prepare H2S-releasing polymers.
29
Based on the versatility and robustness of SATOs, we sought to
prepare a new type of supramolecular H2S donor that exhibited
sustained release, would possess enhanced pharmacokinetics in
vivo, and could be further functionalized for speciﬁc tissue
targeting to solid tumors.
To prepare a SATO-containing polymer amphiphile, a
PEGylated chain transfer agent (CTA) for reversible
addition−fragmentation chain transfer (RAFT) polymerization
was synthesized. This macroCTA was employed in RAFT
polymerization of 2-(4-formylbenzoyloxy)ethyl methacrylate
(FBEMA) in the presence of 2,2′-azobis(2-methylpropionitrile)
(AIBN) to produce a block copolymer of the form PEG-b-
poly(FBEMA) (Figure 1A). The block polymer was of narrow
dispersity (Đ = 1.05) with a monomodal molecular weight
distribution (Figures 1B and S8). A high degree of chain end
functionalization with the desired PEG block was conﬁrmed by
comparing polymer number-average molecular weights (Mns)
measured by SEC (13.8 kDa), calculated from monomer
conversions (13.5 kDa), and determined by 1H NMR end
group analysis (13.2 kDa).
The thiocarbonyl-thio moiety can react with nucleophiles
such as thiols to yield a variety of sulfur-containing byproducts,
including H2S.
36 Therefore, the trithiocarbonate end groups at
the ω-chain ends were displaced by using an excess of AIBN in
reﬂuxing dioxane (Figures 1A and S12), as reported
previously.29 The polymer was then treated with 2 equiv of
S-benzoylthiohydroxylamine in the presence of catalytic
triﬂuoroacetic acid (TFA) to aﬀord block copolymer 1. 1H
NMR spectroscopy conﬁrmed complete SATO formation.
Importantly, SATO formation did not increase the modality of
the SEC trace (Figure S8); the expected increase in molecular
weight was observed (from 13.8 kDa to 17.9 kDa) in
accordance with the added mass of the newly formed SATOs
(Table S1).
To prepare H2S-releasing micelles, the block copolymers
were dissolved in THF, diluted with an equal volume of H2O,
and dialyzed against H2O for 48 h. TEM revealed uniform
spherical particles of average diameter of 21 ± 2 nm (Figures
1D and S12). This diameter represents the dimension of the
hydrophobic micelle core, as the hydrophilic PEG coronae are
not typically observed via TEM. The observed core diameter
matches the expected value for spherical micelles of ∼19 nm
calculated assuming fully extended SATO block chains. DLS
further conﬁrmed a single population of aggregates of diameter
38 ± 4 nm (Figure S9). The slightly smaller size obtained from
TEM is unsurprising as TEM is conducted on dried samples
that do not possess extended hydration spheres.37 The micelles
were stable in DI H2O and in PBS buﬀer (pH = 7) over a
period of 24 h (Figure S10). Their critical aggregation
concentration measured via the Nile red assay was 10 μg/mL
(Figure S13).
The kinetics of H2S release were measured with the
methylene blue assay.38 By monitoring the absorbance over
time, the relative rate of methylene blue formation can be
measured and correlated to the rate of H2S release.
17,39 H2S
release could also be triggered by other biologically relevant
thiols such as glutathione (GSH);17 however, GSH reduces
methylene blue to the noncolored leucomethylene blue, making
quantiﬁcation of half-lives by the methylene blue assay
diﬃcult.40 H2S release kinetic experiments were carried out in
the presence of Zn(OAc)2 to capture the H2S as it was released
by the micelles. From these data, the pseudo-ﬁrst-order half-life
of H2S release from the micelles triggered by Cys was calculated
to be 3.3 ± 0.4 h (Figure 2). As expected, this half-life is
signiﬁcantly longer than that measured for a related small
molecule SATO (t1/2 = 22 min). We attribute this diﬀerence in
rate to the slow diﬀusion of the Cys trigger into the
hydrophobic cores of the polymer micelles. The concentration
proﬁle of H2S released from the micelles was also determined
by conducting the methylene blue assay in the absence of the
trapping agent Zn(OAc)2. The concentration of H2S at each
time point was then calculated using a calibration curve. In this
experiment, H2S concentration reached a peaking value of ∼9.5
μM after 1 h before slowly falling oﬀ (Figure S17). This low
concentration of H2S relative to H2S donor is unsurprising
Figure 1. Synthesis of SATO-containing polymer 1. (A) Synthetic
route. Experimental conditions: (i) FBEMA, AIBN, DMF, 70 °C; (ii)
AIBN, dioxane, reﬂux; (iii) CH2Cl2, molecular sieves, TFA (cat), rt.
(B) SEC trace of polymer 1. (C) 1H NMR spectrum before (bottom
trace) and after (top trace) SATO formation. Dashed lines at 10.0 and
8.6 ppm highlight the aldehyde and SATO resonances, respectively.
(D) Conventional TEM image and schematic illustration of self-
assembled micelles of polymer 1.
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given the slow release rate of the micelles and the transient
nature of H2S.
We investigated the impact of the slow, sustained release of
H2S from SATO-functionalized micelles versus its burst release
from Na2S in cell viability by using a clonogenic assay. As a
proof-of-concept, we selected two well-established and
contrasting cellular models: HCT116 colon carcinoma cells,
the model of choice for many cancer biology studies, and
immortalized NIH/3T3 ﬁbroblasts, a spontaneously generated
cell line that retains major normal characteristics and is
considered the “normal” standard for comparisons with
transformed cells. These cell lines, besides being relatively
easy to manipulate, have been shown to be, in the case of
HCT116, invasive and motile in vitro,41,42 highly tumorigenic
in xenograft experiments,43 and metastatic in orthotopic
models;44 whereas NIH/3T3 ﬁbroblasts retain major normal
cell characteristics including contact inhibition and monolayer
growth and are incapable of inducing tumorigenesis when
injected into animals.45
Experiments were performed by treating cells with micelles
of polymer 1 in the presence or absence of Cys, Cys alone, and
various other controls for 24 h, followed by quantiﬁcation of
the number of viable cells in each treatment group. A
signiﬁcant, concentration-dependent decrease in cell viability
was observed for HCT116 cells treated with active micelles in
the presence of added Cys (Figure 3A). H2S released from
micelles of polymer 1 led to a less pronounced, but still evident,
decrease in viability for NIH/3T3 cells. Other related studies
show an increase in NIH/3T3 cell viability with added H2S.
39,46
The reason for the discrepancy between our studies here and
previous reports is unclear, but it may be due to the rate of H2S
release or minor diﬀerences in how the experiments were
conducted. No signiﬁcant decrease in viability was observed for
either cell line for micelles in the absence of Cys (which would
not produce H2S) or Cys alone (Figure 3B). Additionally,
inactive micelles prepared from a precursor to polymer 1 that
lacked SATO functionalization (and cannot produce H2S) had
a similarly negligible eﬀect on the viability of HTC116 or NIH/
3T3 cells, both with and without added Cys. Finally, cells were
treated with byproducts of the H2S-releasing reaction, shown in
Scheme S1, to determine their eﬀect on cell viability. A solution
of spent micelles was prepared by treating the micelles with 1
mM Cys in PBS buﬀer for 24 h. This spent micelle solution was
assumed to contain both N-benzoylcysteine and cystine based
on previous experiments with small molecule SATOs.17 The
spent micelle solution exhibited no signiﬁcant cytotoxicity
Figure 2. Kinetic analyses of H2S release from micelles prepared from
polymer 1. (A) Raw output from methylene blue assay highlighting the
increase in absorption at 750 nm. (B) Pseudo-ﬁrst-order kinetic plot of
H2S release reaction. Reactions were conducted at [SATO] = 250 μM
in the presence of 1 mM Cys and 2 mM Zn(OAc)2 in phosphate
buﬀer (pH = 7).
Figure 3. Clonogenic survival assay. (A) Titration of cells with active
micelles prepared from polymer 1 in the presence of 1 mM Cys.
Statistical signiﬁcance was determined by paired t test; *** indicates p
< 0.001 compared to cell media alone. (B) Control experiments
demonstrating that toxicity toward cancer cells derives from H2S
release from the active micelles, which only occurs in the presence of
Cys. Polymer concentration was held constant at 8.3 μM, and Cys was
applied at 1 mM in all cases. (C) Comparison of the eﬀect of active
micelles to other common H2S donors on cell viability. Donor
concentration was 250 μM for all experiments (in terms of [SATO]
for the micelles), and Cys was applied at 1 mM where noted. Statistical
signiﬁcance was determined by paired t test; *** indicates p < 0.001
compared to active micelles. In all experiments, clonogenic assays of
NIH/3T3 and HCT116 cells (red and gray bars, respectively) were
performed in 6-well plates after treatment for 24 h. Data are presented
as the mean ± SD from 2−3 independent experiments performed in
triplicate.
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toward either cell line (Figure S15A). The cells were also
treated with NH4Cl, a source of NH4
+, which we hypothesize is
formed as a byproduct of H2S release. The applied NH4Cl did
not reduce cell viability in the concentration range tested
(Figure S15B). Taken together, these control experiments
suggest that the observed decrease in viability in HTC116 cells
treated with active micelles originates from H2S. Importantly,
the diﬀerence in the survival of the two cell types indicates
some selectivity for these micelles in killing cancer cells.
In addition, the reduction in cell viability observed with H2S-
releasing micelles of polymer 1 was compared to other
common H2S donors (Figure 3C), including Na2S, SATO1
(a small molecule SATO ((C6H5)COSNCH(C6H4)-
COOH)), and GYY4137 (an H2S donor with a release half-
life on the order of days−weeks). In all cases, the H2S-releasing
micelles signiﬁcantly decreased cell viability in HCT116 cells
compared to alternative H2S donors. No signiﬁcant changes in
viability were observed for NIH/3T3 cells across the diﬀerent
donor types. We attribute the enhanced toxicity of the micelles
toward HCT116 cells compared to that of alternative donors to
release rate. More mechanistic studies will be needed to
optimize dosage and release rates and to identify any selective
intermediary molecules involved.
■ CONCLUSIONS
In summary, we have prepared H2S-releasing micelles based on
SATO-functionalized polymer amphiphiles. The micelles
signiﬁcantly reduced the survival of HCT116 cells compared
to other common H2S donors, including Na2S, a small molecule
SATO, and GYY4137. Promisingly, the micelles were well
tolerated by healthy NIH/3T3 cells. These H2S-releasing
micelles provide a valuable tool for studying H2S in biological
systems, both in vitro and as potential targeted H2S delivery
vehicles in vivo.
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